Form 4 for GILD Gilead Sciences

Accepted 2026-08-04 17:40:36 ET · period of report 2026-08-03 · accession 0001638643-26-000028 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MT	2026-08-04 17:40	2026-08-03	GILD	O'Day Daniel Patrick	COB, CEO, Dir	S - Sale	$130.31	-15.0K	592.1K	-2%	-$1.95M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-08-03	S	D	6,700	$129.66	600,433	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F2) Sale prices for the transactions reported range from $129.17 to $130.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
2	Common	Common Stock	2026-08-03	S	D	7,700	$130.80	592,733	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F3) Sale prices for the transactions reported range from $130.18 to $131.17. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
3	Common	Common Stock	2026-08-03	S	D	600	$131.34	592,133	D	—	—	(F1) The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. (F4) Sale prices for the transactions reported range from $131.21 to $131.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.